1. European Network for Health Technology Assessment Levels of evidence – Applicability of evidence in the context of a relative effectiveness assessment of pharmaceuticals (2012); http://www.eunethta.eu/outputs/methodological-guideline-rea-pharmaceuticals-direct-and-indirect-comparison [contrôlé juillet 2013].
2. Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care;Chapman;BMJ,2003
3. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement;Neumann;Health Aff (Millwood),2011
4. Guidelines for deeds of agreement for the pharmaceutical benefits scheme Contract No.: 1. 3. Camberra;Australian Government Departement of Health and Ageing,2009
5. European CommissionImpact assessment of the proposal for a directive of the european parliament and of the council relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems, COM(2012) 84 final 2012/0035.